Abstract
Background:
Early diagnosis and expeditious treatment of newborns with congenital hypothyroidism (CH) is necessary to avoid mental retardation.
Methods:
A survey of 44 practitioners in the southern US was conducted to better understand common practices regarding neonatal CH and the findings were compared with current guidelines in the US and Europe.
Results:
Responses indicated some consensus that 10–15 μg of thyroid hormone/kg/day was the appropriate dosage. However, despite guidelines advocating their use, practitioners reported that they did not commonly use imaging or laboratory tests, though experienced providers apparently used them more often.
Conclusions:
Together, these results show moderate adherence to published guidelines for treating and diagnosing CH. Further research is needed to determine why providers deviate from these guidelines and to generalize these results to other populations.
Acknowledgments
This study was conducted as part of the University of North Texas Health Science Center and Cook Children’s Pediatric Research Program (PRP). The authors would like to acknowledge Karen Keller, Dena Hanson and Ashley Brock for their assistance in preparing and editing this manuscript.
Author contributions: All the authors have accepted responsibility for the entire content of this submitted manuscript and approved submission.
Research funding: None declared.
Employment or leadership: None declared.
Honorarium: None declared.
Competing interests: The funding organization(s) played no role in the study design; in the collection, analysis, and interpretation of data; in the writing of the report; or in the decision to submit the report for publication.
References
1. Rose SR, Brown RS, Foley T, Kaplowitz PB, Kaye Cl, et al. Update of newborn screening and therapy for congenital hypothyroidism. Pediatrics 2006;117:2290–303.10.1542/9781581108613-part05-updateSearch in Google Scholar
2. Abduljabbar MA, Afifi AM. Congenital hypothyroidism. J Pediatr Endocrinol Metab 2012;25:13–29.10.1515/jpem.2011.408Search in Google Scholar PubMed
3. Leger J, Olivieri A, Donaldson M, Torresani T, Krude H, et al. European society for pediatric endocrinology consensus guidelines on screening, diagnosis and management of congenital hypothyroidism. Horm Res Paediatr 2014;81:80–103.10.1159/000358198Search in Google Scholar PubMed
4. Jones JH, Donaldson MD. Audit of initial management of congenital hypothyroidism in the United Kingdom – comparison of UK practice with European and UK guidelines. J Pediatr Endocrinol Metab 2009;22:1017–25.10.1515/JPEM.2009.22.11.1017Search in Google Scholar PubMed
5. Jusiene R, Kucinskas V. Psychological adjustment of children with congenital hypothyroidism and phenylketonuria as related to parental psychological adjustment. Medicina 2004;40:663–70.Search in Google Scholar
6. Donaldson M, Jones J. Optimising outcome in congenital hypothyroidism; current opinions on best practice in initial assessment and subsequent management. J Clin Res Pediatr Endocrinol 2013;5:13–22.10.4274/jcrpe.849Search in Google Scholar PubMed PubMed Central
7. LaFranchi SH, Austin J. How should we be treating children with congenital hypothyroidism? J Pediatr Endocrinol Metab 2007;20:559–78.10.1515/JPEM.2007.20.5.559Search in Google Scholar PubMed
8. Hobbs FD, Erhardt L. Acceptance of guideline recommendations and perceived implementation of coronary heart disease prevention among primary care physicians in five European countries: the Reassessing European Attitudes about Cardiovascular Treatment (REACT) survey. Fam Pract 2002;19:596–604.10.1093/fampra/19.6.596Search in Google Scholar PubMed
9. Eaton CB, Galliher JM, McBride PE, Bonham AJ, Kappus JA, et al. Family physician’s knowledge, beliefs, and self-reported practice patterns regarding hyperlipidemia: a National Research Network (NRN) survey. J Am Board Fam Med 2006;19:46–53.10.3122/jabfm.19.1.46Search in Google Scholar PubMed
10. Parker DR, Gramling R, Goldman RE, Eaton CB, Ahern D, et al. Physicians’ perceptions of barriers and facilitators regarding adoption of the National Cholesterol Education Program guidelines. Prev Cardiol 2008;11:29–35.10.1111/j.1520-037X.2007.07200.xSearch in Google Scholar PubMed
©2017 Walter de Gruyter GmbH, Berlin/Boston
Articles in the same Issue
- Frontmatter
- Review
- Imaging methods for bone mass evaluation during childhood and adolescence: an update
- Original Articles
- Risk factors for overweight and obesity in children aged 2–6 years
- Copy number variations in “classical” obesity candidate genes are not frequently associated with severe early-onset obesity in children
- Trends in the prevalence of extreme obesity among Korean children and adolescents from 2001 to 2014
- Plasma but not serum brain-derived neurotrophic factor concentration is decreased by oral glucose tolerance test-induced hyperglycemia in children
- Environmental and genetic determinants of two vitamin D metabolites in healthy Australian children
- Evaluation of vitamin D prophylaxis in 3–36-month-old infants and children
- Possible effects of neonatal vitamin B12 status on TSH-screening program: a cross-sectional study from Turkey
- Effects of L-thyroxine treatment on heart functions in infants with congenital hypothyroidism
- Hyperandrogenism in adolescent girls: relationship with the somatotrophic axis
- Plasma kisspeptin and ghrelin levels in puberty variant cases
- Genotype-phenotype correlation in paediatric pheochromocytoma and paraganglioma: a single centre experience from India
- Short Communication
- Provider variability in the initial diagnosis and treatment of congenital hypothyroidism
- Case Reports
- Giant parathyroid adenoma associated with severe hypercalcemia in an adolescent patient
- Personalized precision medicine in extreme preterm infants with transient neonatal diabetes mellitus
- Pseudohypoaldosteronism types I and II: little more than a name in common
- Primary pigmented nodular adrenocortical disease: literature review and case report of a 6-year-old boy
Articles in the same Issue
- Frontmatter
- Review
- Imaging methods for bone mass evaluation during childhood and adolescence: an update
- Original Articles
- Risk factors for overweight and obesity in children aged 2–6 years
- Copy number variations in “classical” obesity candidate genes are not frequently associated with severe early-onset obesity in children
- Trends in the prevalence of extreme obesity among Korean children and adolescents from 2001 to 2014
- Plasma but not serum brain-derived neurotrophic factor concentration is decreased by oral glucose tolerance test-induced hyperglycemia in children
- Environmental and genetic determinants of two vitamin D metabolites in healthy Australian children
- Evaluation of vitamin D prophylaxis in 3–36-month-old infants and children
- Possible effects of neonatal vitamin B12 status on TSH-screening program: a cross-sectional study from Turkey
- Effects of L-thyroxine treatment on heart functions in infants with congenital hypothyroidism
- Hyperandrogenism in adolescent girls: relationship with the somatotrophic axis
- Plasma kisspeptin and ghrelin levels in puberty variant cases
- Genotype-phenotype correlation in paediatric pheochromocytoma and paraganglioma: a single centre experience from India
- Short Communication
- Provider variability in the initial diagnosis and treatment of congenital hypothyroidism
- Case Reports
- Giant parathyroid adenoma associated with severe hypercalcemia in an adolescent patient
- Personalized precision medicine in extreme preterm infants with transient neonatal diabetes mellitus
- Pseudohypoaldosteronism types I and II: little more than a name in common
- Primary pigmented nodular adrenocortical disease: literature review and case report of a 6-year-old boy